Genelink Profit Margin

The latest profit margin for GNLKQ is -128.81% as of September 2013. That compares with -136.21% in the prior-year period — up 5.4% year over year. That is below the Healthcare sector average of 19.13%. Investors often review this figure alongside Genelink's historical trend and sector peers before judging valuation or financial health.

Over the past year, GNLKQ's profit margin moved from -136.21% to -128.81% — a 5.4% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Genelink's valuation or profitability profile.

Against Healthcare companies, GNLKQ currently prints -128.81% for profit margin, while the sector average sits near 19.13%. That is roughly 773.3% below the sector mean. Large gaps often invite a closer look at Genelink's growth, margins, and balance sheet.

Profit Margin shows how effectively Genelink converts resources into returns. At -128.81%, GNLKQ may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -136.21% in the prior-year period — up 5.4% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting GNLKQ's profit margin (-128.81%), review year-over-year change from -136.21%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.